High LDL cholesterol caused 3.6 million deaths globally in 2023. India and China bore one-third of this worldwide disease burden. The number of adults with elevated LDL-C levels significantly increased since 1990. Statins remain crucial for management but face underuse and access barriers. Strengthening primary healthcare and diagnostics is essential for better treatment.

Cholesterol-related diseases are rising sharply worldwide, with the burden concentrated in India, China, and other lower-income regions where screening and statin access remain…

Unlike in many other geographies, where cholesterol imbalance worsens with age, Indians get hit harder at a much younger age